Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Resources>Application Notes>This Application Note
  Application Notes
Scientific News
Criminal Justice Alcohol Program Linked to Decreased Mortality
Institute has announced that in the criminal justice alcohol program deaths dropped by 4.2 percent over six years.
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Scroll Up
Scroll Down

Efficient PCR from whole blood using Finnzymes High Performance PCR solution
Bookmark and Share


Labtech International

Finnzymes have developed a range of reagents,consumables and instrumentation to allow fastPCR in inhibiting conditions. Here we describean application for amplifying exogenous andhuman genomic DNA from whole blood withoutthe need for DNA purification, and use ofspecial buffers or complicated protocols.Finnzymes' solution for High Performance (HP)-PCR results in faster amplification with betteryields for raw blood samples as compared withconventional methods for PCR.

Finnzymes’ HP-PCR is a tripartite solution focused onspeeding up a PCR and providing marked improvementsin yield while maintaining high fidelity. The uniquecombination of our highly processive PhusionTM DNAPolymerases, quick PikoTM Thermal Cyclers and ultra-thinwalled UTWTM tubes provides considerable benefits to thespeed, yield, fidelity, specificity and robustness of PCR.Central to these improvements is our Phusion technology,which enhances activity by way of a double-strandedDNA-binding domain bound to a highly engineeredproofreading polymerase. This dsDNA-binding domainallows for ultra-robust reactions by tethering thepolymerase to the duplex DNA, driving much higherassociation constants, so the effects of conventionalinhibitors of PCR are significantly reduced1. Here wedescribe one such application, a simple protocol for robustamplification of DNA from whole blood. Whole blood isoften used in clinical diagnostics and as a DNA source forPCR tests. Unfortunately, Taq DNA polymerase, the mostcommonly used enzyme for PCR, is known to becompletely inhibited by even small quantities of wholeblood in the reaction2. Several strategies have been usedto overcome this difficulty, including the use of specializedpurifications, buffers and pretreatments3,4, but all of thesemethods have drawbacks, adding time and cost, and oftenproducing inconsistent results. As a consequence,purification of genomic DNA from whole blood remains acommon practice even though it adds considerable timeand expense to the test.

Further Information


Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!